TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15035551

Group type: EXPERIMENTAL
Intervention: 10 mg of terbutaline daily for 15 days starting on the day of oocyte retrieval (Group I)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: 20 mg of ritodrine daily for 15 days (Group II)
Number of subjects: 225

Group type: COMPARATOR
Intervention: No treatment (Group III)
Number of subjects: 225
Study: 10695846

Group type: EXPERIMENTAL
Intervention: Muncie method (home rehabilitation with modified VMO specific straight leg raise)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Traditional home rehabilitation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 64
Study: 9177555

Group type: EXPERIMENTAL
Intervention: Target stimulus probability at 0.33
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Target stimulus probability at 0.67
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interstimulus interval (ISI) of 2 s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interstimulus interval (ISI) of 6 s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimulus sequence types (SS, TS, TT, ST)
Number of subjects: 0
Study: 7697065

Group type: EXPERIMENTAL
Intervention: Arginine vasotocin (AVT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Tricyclic antidepressants or cognitive-behavioral psychotherapy
Number of subjects: 33
Study: 2869050

Group type: EXPERIMENTAL
Intervention: Methimazole (2 months before and 3 months after 131I therapy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Betamethasone (3 weeks before and 4 weeks after 131I therapy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 131I alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Methimazole and 131I
Number of subjects: 60
Study: 30482676

Group type: EXPERIMENTAL
Intervention: Herbal tea (Astragali Radix, Angelicae gigantis Radix, Zizyphi Fructus) consumed twice daily for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 27106570

Group type: EXPERIMENTAL
Intervention: Video-modeling brushing intervention delivered over the internet for 3 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control video condition
Number of subjects: 18
Study: 24480774

Group type: EXPERIMENTAL
Intervention: DBM grafts placed between the proximal and distal segments
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no grafts performed)
Number of subjects: 48
Study: 23069726

Group type: EXPERIMENTAL
Intervention: Lubricant eye drops containing hydroxypropyl‐guar (HP‐guar) gelling agent (Systane Ultra)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lubricant eye drops without gelling agent (Refresh Tears)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: HP‐guar group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 20554640

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise programme (3-6 weeks)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise programme
Number of subjects: 21

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 21
Study: 18407418

Group type: EXPERIMENTAL
Intervention: Lyophilized bovine collagen (gelfix spray)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard dressing)
Number of subjects: 0
Study: 15745938

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 12271411

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 50 mg twice a day for 5 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (low-iodine diet only)
Number of subjects: 18

Group type: COMPARATOR
Intervention: HCTZ group vs Control group
Number of subjects: 18
Study: 10077366

Group type: EXPERIMENTAL
Intervention: Stapled closure with RLV 30 Ethicon 4.8 mm bronchial stapler
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hand sutured with 4 0 Prolene simple interrupted sutures
Number of subjects: 40
Study: 7737863

Group type: EXPERIMENTAL
Intervention: Transnasal butorphanol
Number of subjects: 157

Group type: COMPARATOR
Intervention: Transnasal placebo
Number of subjects: 157
Study: 2248695

Group type: EXPERIMENTAL
Intervention: Magnesium-rich diet (group A, 206 participants)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual diet (group B, 194 participants)
Number of subjects: 400
Study: 6118171

Group type: EXPERIMENTAL
Intervention: Atenolol 0.2 mg/kg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Betaxolol 0.15 mg/kg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Betaxolol 0.6 mg/kg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Practolol 1 mg/kg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Propranolol 0.2 mg/kg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 14
Study: 31793882

Group type: EXPERIMENTAL
Intervention: PCI with everolimus‐eluting stents for trifurcation disease
Number of subjects: 605

Group type: COMPARATOR
Intervention: PCI with everolimus‐eluting stents for bifurcation disease
Number of subjects: 605
Study: 30165458

Group type: EXPERIMENTAL
Intervention: Total 3HC/Free COT during early pregnancy (12.5 weeks gestation)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Total 3HC/Free COT during late pregnancy (28.9 weeks gestation)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Total 3HC/Free COT postpartum (6 months after childbirth)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Free 3HC/Free COT during early pregnancy (12.5 weeks gestation)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Free 3HC/Free COT during late pregnancy (28.9 weeks gestation)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Free 3HC/Free COT postpartum (6 months after childbirth)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Total 3HC/Total COT over time
Number of subjects: 47
Study: 30235767

Group type: EXPERIMENTAL
Intervention: Color Density Spectral Array (CDSA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amplitude-Integrated Electroencephalography (aEEG)
Number of subjects: 30
Study: 26710009

Group type: EXPERIMENTAL
Intervention: Silicone implants
Number of subjects: 50979

Group type: COMPARATOR
Intervention: Saline implants
Number of subjects: 50979
Study: 24168904

Group type: EXPERIMENTAL
Intervention: Dairy protein intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total protein intake
Number of subjects: 0
Study: 23231757

Group type: EXPERIMENTAL
Intervention: EAAMR (Essential Amino Acids Meal Replacement)
Number of subjects: 12

Group type: COMPARATOR
Intervention: CMR (Competitive Meal Replacement)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EAAMR
Number of subjects: 12

Group type: COMPARATOR
Intervention: CMR
Number of subjects: 12
Study: 19863513

Group type: EXPERIMENTAL
Intervention: 20% aminolaevulinic acid (ALA)-PDT
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo-PDT
Number of subjects: 45
Study: 17344325

Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin (80 mg daily)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Low-dose atorvastatin (10 mg daily)
Number of subjects: 112
Study: 15895534

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11869201

Group type: EXPERIMENTAL
Intervention: Long pulse 532 nm potassium tritanyl phosphate (KTP) laser treatment for perialar vessels
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Long pulse 532 nm potassium tritanyl phosphate (KTP) laser treatment for spider naevi
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Long pulse 532 nm potassium tritanyl phosphate (KTP) laser treatment for both conditions
Number of subjects: 39
Study: 9022602

Group type: EXPERIMENTAL
Intervention: Oral estrone sulfate
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Transdermal E2
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Estrogen therapy in hypertensive women
Number of subjects: 18
Study: 7835208

Group type: EXPERIMENTAL
Intervention: Patients with liver cirrhosis and diabetes mellitus (Group I)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Matched patients with only Type II DM (Group II)
Number of subjects: 34
Study: 3277366

Group type: EXPERIMENTAL
Intervention: Digoxin (titrated to a level of 1.54 to 2.56 nmol/liter)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30321323

Group type: EXPERIMENTAL
Intervention: Closed surgical exposure (n = 60)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Open surgical exposure (n = 59)
Number of subjects: 119
Study: 27383389

Group type: EXPERIMENTAL
Intervention: Internet-based counselor guidance (choice group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Internet-based counselor guidance (messages group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Self-help program without guidance (control group)
Number of subjects: 80
Study: 24659155

Group type: EXPERIMENTAL
Intervention: 12-week exercise training
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 12-week relaxation training
Number of subjects: 96

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 96
Study: 23367230

Group type: EXPERIMENTAL
Intervention: NMES therapy of quadriceps femoris and tibialis anterior muscles
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional physiotherapy alone
Number of subjects: 10
Study: 20367845

Group type: EXPERIMENTAL
Intervention: Multisystemic therapy
Number of subjects: 0
Study: 17912003

Group type: EXPERIMENTAL
Intervention: 200 mg oral mifepristone
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 16183952

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 5464

Group type: COMPARATOR
Intervention: No adjuvant chemotherapy
Number of subjects: 5464
Study: 15587176

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1.875 mg x kg(‐1)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.9375 mg x kg(‐1)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5625 mg x kg(‐1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study: 10689949

Group type: EXPERIMENTAL
Intervention: Prednisolone (maximum of 15 mg daily)
Number of subjects: 320
Study: 9132132

Group type: EXPERIMENTAL
Intervention: Temporal scleral incision made 2 mm posterior to the limbus
Number of subjects: 256

Group type: COMPARATOR
Intervention: Incisions in the 12 o'clock position
Number of subjects: 256

Group type: COMPARATOR
Intervention: Limbal incisions in the 12 o'clock position
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Temporal limbal incision
Number of subjects: 256

Group type: COMPARATOR
Intervention: Incision depth of 300 microns versus 500 microns
Number of subjects: 256

Group type: COMPARATOR
Intervention: Age
Number of subjects: 256

Group type: COMPARATOR
Intervention: Preoperative astigmatism
Number of subjects: 256
Study: 8112904

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Enalapril in patients with heart failure
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo in patients with heart failure
Number of subjects: 99
Study: 3533089

Group type: EXPERIMENTAL
Intervention: Bay m 1099 (50 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3276591

Group type: EXPERIMENTAL
Intervention: Nadolol (40 to 120 mg per day)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (placebo and ranitidine combined)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study: 30374739

Group type: EXPERIMENTAL
Intervention: Nymphs kept at 400 ppm CO2 level and fed on plants grown at 700 ppm CO2 level
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nymphs kept at 700 ppm CO2 level and fed on plants grown at 400 ppm CO2 level
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nymphs and plants kept at 700 ppm CO2 level
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nymphs and plants kept at 400 ppm CO2 level
Number of subjects: 50
Study: 30183818

Group type: EXPERIMENTAL
Intervention: Higher starting point in face-to-face interviews
Number of subjects: 147

Group type: COMPARATOR
Intervention: Lower starting point in face-to-face interviews
Number of subjects: 147
Study: 26119285

Group type: EXPERIMENTAL
Intervention: Cream with aqueous extract from leaf of five-leaf serratula containing 2.51% of arbutin applied twice a day for 8 weeks
Number of subjects: 102
Study: 23816030

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1498

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1498
Study: 21707560

Group type: EXPERIMENTAL
Intervention: Clonidine (150 μg) added to epidural low-concentration levobupivacaine (0.0625%) plus sufentanil (0.45 μg.ml(‐1))
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (no clonidine)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Clonidine (150 μg) added to epidural solution
Number of subjects: 115
Study: 19754965

Group type: EXPERIMENTAL
Intervention: CASCADE psycho-educational programme delivered in 4 group sessions over 4 months.
Number of subjects: 572

Group type: COMPARATOR
Intervention: Standard care from clinical team (control group).
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: CASCADE psycho-educational programme.
Number of subjects: 572
Study: 16443418

Group type: EXPERIMENTAL
Intervention: Intravenous hydration for 12 hours before contrast exposure, followed by hemofiltration for 18 to 24 hours after contrast exposure (post‐hemofiltration group; n = 31)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Hemofiltration performed for 6 hours before and for 18 to 24 hours after contrast exposure (pre/post‐hemofiltration group; n = 31)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Intravenous hydration with isotonic saline (1 mL x kg x h for 12 hours before and after contrast exposure, control group; n = 30)
Number of subjects: 92
Study: 14980556

Group type: EXPERIMENTAL
Intervention: Sulpiride (dopaminergic drug treatment)
Number of subjects: 0
Study: 11816626

Group type: EXPERIMENTAL
Intervention: AAIR pacing
Number of subjects: 19

Group type: COMPARATOR
Intervention: DDDR pacing
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Preference
Number of subjects: 19
Study: 9273190

Group type: EXPERIMENTAL
Intervention: Concomitant chemotherapy with daily doses of carboplatin (20 to 25 mg/m2/d over 45 or 10 min) and accelerated chest irradiation (60 to 64 Gy over 4 weeks, 2 Gy per fraction)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Concomitant chemotherapy with daily doses of carboplatin and accelerated chest irradiation
Number of subjects: 15
Study: 8487562

Group type: EXPERIMENTAL
Intervention: Warm cardioplegia
Number of subjects: 53

Group type: COMPARATOR
Intervention: Cold cardioplegia
Number of subjects: 53
Study: 3306068

Group type: EXPERIMENTAL
Intervention: Danazol 200 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Danazol 300 mg per day
Number of subjects: 0
Study: 29362255

Group type: EXPERIMENTAL
Intervention: Home exercise programme using Physitrack (online exercise prescription tool) for 8 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Home exercise programme without Physitrack for 8 weeks
Number of subjects: 58
Study: 27038608

Group type: EXPERIMENTAL
Intervention: CT-P13 (3 mg/kg)
Number of subjects: 606

Group type: COMPARATOR
Intervention: RP (3 mg/kg)
Number of subjects: 606
Study: 26686362

Group type: EXPERIMENTAL
Intervention: 2 Gy radiation prescribed to primary tumour
Number of subjects: 36

Group type: COMPARATOR
Intervention: No radiation prescribed to primary tumour
Number of subjects: 36
Study: 23052751

Group type: EXPERIMENTAL
Intervention: Enhanced recovery protocols including early laparoscopic cholecystectomy, restrictive endoscopic intervention, and early oral nutrition
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional recovery (TR) protocols
Number of subjects: 60
Study: 19947898

Group type: EXPERIMENTAL
Intervention: 500 mg quercetin/day with 125 mg vitamin C/day
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: 1000 mg quercetin/day with 250 mg vitamin C/day
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1002
Study: 20428412

Group type: EXPERIMENTAL
Intervention: Duloxetine 60/120 mg once daily
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 16386400

Group type: EXPERIMENTAL
Intervention: Psychosocial questions from the physician during the medical interview
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Medical interview with physicians varying their communication
Number of subjects: 54
Study: 12809836

Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg p.o. t.i.d. for 4 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo p.o. t.i.d. for 4 weeks
Number of subjects: 16
Study: 10397378

Group type: EXPERIMENTAL
Intervention: Oral administration of 600 mg clomethiazole edisylate (390 mg clomethiazole base)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rectal administration of 600 mg clomethiazole edisylate (390 mg clomethiazole base)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral administration of 600 mg clomethiazole edisylate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rectal administration of 600 mg clomethiazole edisylate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both oral and rectal administration of 600 mg clomethiazole edisylate
Number of subjects: 10
Study: 8724944

Group type: EXPERIMENTAL
Intervention: Method based on reintroduction of letter forms (visual and verbal explanation)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Method based on copying exercises
Number of subjects: 38
Study: 1874487

Group type: EXPERIMENTAL
Intervention: Thymosin fraction 5 or thymosin‐alpha 1
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6630111

Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanic acid with probenecid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amoxycillin alone
Number of subjects: 0
Study: 31869656

Group type: EXPERIMENTAL
Intervention: Primary care-based treatment
Number of subjects: 110

Group type: COMPARATOR
Intervention: Hospital-based care
Number of subjects: 110
Study: 30161238

Group type: EXPERIMENTAL
Intervention: Preferred choice of housing (staying at home)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Actual choice of housing
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Role in decision-making
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Decisional conflict score
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Decision regret score
Number of subjects: 79
Study: 26720730

Group type: EXPERIMENTAL
Intervention: Words presentation format
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Numbers presentation format
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Numbers plus narrative presentation format
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Numbers plus framed presentation format
Number of subjects: 775

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 775
Study: 25366886

Group type: EXPERIMENTAL
Intervention: Short CPR instructions via phone with continuous advice until emergency services arrived (Group 1)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Short CPR instructions via phone, call terminated after information provided (Group 2)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Instructions to start CPR only (Group 3)
Number of subjects: 119
Study: 21796410

Group type: EXPERIMENTAL
Intervention: TENS (30 min, 80 Hz, 150 μs)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (same protocol without electrical output)
Number of subjects: 22
Study: 19520440

Group type: EXPERIMENTAL
Intervention: Integrated care model
Number of subjects: 74

Group type: COMPARATOR
Intervention: Traditional model
Number of subjects: 74
Study: 18579924

Group type: EXPERIMENTAL
Intervention: Monochromatic infrared energy treatment (1.5 J/cm(2)/min at 890 nm)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham treatment (no energy delivered)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both active and sham treatments
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Monochromatic infrared energy treatment
Number of subjects: 18
Study: 16007595

Group type: EXPERIMENTAL
Intervention: Chemotherapy (specific dosage and duration not provided)
Number of subjects: 65
Study: 12401632

Group type: EXPERIMENTAL
Intervention: Clonidine 15-45 micro g
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (Saline)
Number of subjects: 110
Study: 10667283

Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI) at 1.6 mg/kg/day
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 7599771

Group type: EXPERIMENTAL
Intervention: Caremap management
Number of subjects: 251

Group type: COMPARATOR
Intervention: Traditional treatment
Number of subjects: 251
Study: 2082953

Group type: EXPERIMENTAL
Intervention: Hydergine‐LC (1 mg orally three times daily for 24 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 795609

Group type: EXPERIMENTAL
Intervention: 0.05% alcoholic solution of clobetasol propionate
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.05% alcoholic solution of betamethasone-17,21-dipropionate
Number of subjects: 40
Study: 30654808

Group type: EXPERIMENTAL
Intervention: Artesunate (AS) 4 mg/kg/day for 4 days followed by dihydroartemisinin (DHA) 2.2 mg/kg and piperaquine (PPQ) 18 mg/kg daily for 3 days
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Artemether (AM) 1.7 mg/kg and lumefantrine (LUM) 12 mg/kg twice daily for 3 days
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) total 25 mg/kg over 3 days
Number of subjects: 43
Study: 27605986

Group type: EXPERIMENTAL
Intervention: Buccal corticotomy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no buccal corticotomy)
Number of subjects: 15
Study: 24838476

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg/d)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 22623468

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide dressing (Group A)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No intracanal medication (Group B)
Number of subjects: 70